Protara Therapeutics (TARA) Short-Term Debt issuances (2020)
Protara Therapeutics' (TARA) quarterly Short-Term Debt issuances came in at $3.0 million in Q4 2020, up 632.68% on a QoQ basis from -$557000.0 in Q3 2020.
Protara Therapeutics (TARA) Short-Term Debt issuances (2020) Analysis & Trends
Protara Therapeutics (TARA) has 1 years of Short-Term Debt issuances data on file, last reported at $3.0 million in Q4 2020.
- On a quarterly basis, Short-Term Debt issuances changed N/A year-over-year to $3.0 million in Q4 2020; TTM through Dec 2020 was $1.7 million, a N/A change from a year earlier, with the FY2020 full-year figure at $1.7 million, changed N/A from the prior year.
- Short-Term Debt issuances for Q4 2020 stood at $3.0 million, up from -$557000.0 in the prior quarter.
- Over the last five years, Short-Term Debt issuances for TARA reached as high as $3.0 million in Q4 2020 and fell as low as -$557000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 58.20 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protara Therapeutics | 2.25 Mn | 2.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.97 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | -557,000.00 |
| Sep 30, 2020 | -557,000.00 |
| Jun 30, 2020 | -371,000.00 |
| Jun 30, 2020 | -371,000.00 |
| Mar 31, 2020 | -370,000.00 |
| Mar 31, 2020 | -370,000.00 |